Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Vanderwerff

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Genetics|March 9, 2021
Why are rare variants hard to impute? Coalescent models reveal theoretical limits in existing algorithmsYichen Si, Brett Vanderwerff, Sebastian Zöllner
Anesthesiology|June 10, 2025
Polygenic Risk for Postoperative Nausea and Vomiting: ReplyNicholas J Douville, Lisa Bastarache, Brett Vanderwerff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancerMary Hwang, Sarah Medley, Faisal Shakeel, et al.
Pharmacogenetics and Genomics|February 7, 2026
The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposureKatherine Zhao, Vy Lam, Gregory Eschenauer, et al.
Genetics|May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variationBrett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Msphere|October 22, 2024
Genetic insight into the relationship between inflammatory bowel disease and <i>Clostridioides difficile</i> infectionKelly C Cushing-Damm, Yanhua Chen, Xiaomeng Du, et al.
Inflammatory Bowel Diseases|January 12, 2022
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerKelly C Cushing, Xiaomeng Du, Yanhua Chen, et al.
Clinical Pharmacology and Therapeutics|May 10, 2023
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data RepositoryAmy L Pasternak, Robinson Seda, Joseph Lipa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Polygenic risk scores for prediction of immune checkpoint inhibitor thyroid toxicity in diverse populationsLars G Fritsche, Luke M Higgins, Matthew Schipper, et al.
Cell Genomics|February 23, 2023
The Michigan Genomics Initiative: A biobank linking genotypes and electronic clinical records in Michigan Medicine patientsMatthew Zawistowski, Lars G Fritsche, Anita Pandit, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Genetics|March 9, 2021
Why are rare variants hard to impute? Coalescent models reveal theoretical limits in existing algorithmsYichen Si, Brett Vanderwerff, Sebastian Zöllner
Anesthesiology|June 10, 2025
Polygenic Risk for Postoperative Nausea and Vomiting: ReplyNicholas J Douville, Lisa Bastarache, Brett Vanderwerff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2022
Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancerMary Hwang, Sarah Medley, Faisal Shakeel, et al.
Pharmacogenetics and Genomics|February 7, 2026
The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposureKatherine Zhao, Vy Lam, Gregory Eschenauer, et al.
Genetics|May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variationBrett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Msphere|October 22, 2024
Genetic insight into the relationship between inflammatory bowel disease and <i>Clostridioides difficile</i> infectionKelly C Cushing-Damm, Yanhua Chen, Xiaomeng Du, et al.
Inflammatory Bowel Diseases|January 12, 2022
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerKelly C Cushing, Xiaomeng Du, Yanhua Chen, et al.
Clinical Pharmacology and Therapeutics|May 10, 2023
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data RepositoryAmy L Pasternak, Robinson Seda, Joseph Lipa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Polygenic risk scores for prediction of immune checkpoint inhibitor thyroid toxicity in diverse populationsLars G Fritsche, Luke M Higgins, Matthew Schipper, et al.
Cell Genomics|February 23, 2023
The Michigan Genomics Initiative: A biobank linking genotypes and electronic clinical records in Michigan Medicine patientsMatthew Zawistowski, Lars G Fritsche, Anita Pandit, et al.
Pageof 3